Usability and Satisfaction With an Electronic Survey Administration Application in General Population (CePRO)
研究概览
详细说明
Patient-reported outcomes (PROs) are vital to understanding the impact of a medical condition and treatment from the participant's perspective. However, the collection of data can be inconsistent in both administration and completion due to the method of delivery. Thus, careful consideration of the data collection mode is needed to ensure the quality of the data. The method of delivery has been shown to have a direct effect on the survey response rates thereby ensuring the validity of the data analyses and results. Previous studies have demonstrated an increase in Web-based survey response rates as compared to paper-based survey response rates. Novel methods of collecting PROs may help to streamline both the process and collection of PROs during clinical trials.
A potential differentiating factor between delivering surveys via smart phone and other electronic modes of delivery is the perceived advantage of being able to conveniently complete survey questionnaires at any time and any location. This could help address certain limitations of the quantitative survey method such as recall bias. Furthermore, the portability, connectivity and ubiquity of smartphones may reduce the amount of training or instructions required for users to complete a survey questionnaire on a smartphone. For researchers, this type of survey delivery method may offer the benefits of a wider target audience and reduce research implementation costs. The e-PRO app is designed to further facilitate the delivery of PRO instruments in a convenient manner to participants. Through its computing capability, and user-friendly interface, the e-PRO app can collect data and implement complex scoring requirements, thus supporting the delivery of self-administered survey questionnaires. The goal of this two-arm randomized controlled pilot is to explore the usability and satisfaction with a novel e-PRO app.
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- Partners HealthCare
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Healthy participants over the age of 18-65 years as assessed by the Self-Rated Health Measure.
- Fluency in English language to be able to read, understand study procedures and complete surveys administered during the study.
- Willing to travel to the downtown Boston area to participate in up to two study visits.
- Willing to participate in the research study and sign informed consent.
Exclusion Criteria:
- Participants with a "fair" or "poor" rating on the Self-Rated Health Measure.
- Participants with EU citizenship or permanent residency
- Participants with severe cognitive, vision, hearing, or speech problems that may prevent them from answering surveys
- Participants with serious psychiatric conditions (moderate or major depressive disorder that may impair their ability to complete surveys
- Participants with any terminal illness (e.g. cancers)
- Patients with implantable devices, pacemakers or body worn electronic medical devices
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
无干预:Control Group
Participants will be enrolled for a period of 4 weeks.
At baseline, we will collect demographic information on participants.
During the study, participants will be asked to fill out daily and weekly surveys using an electronically link sent via email.
Additionally, participants will be asked to fill out one survey once a week during the study period.
|
|
|
实验性的:Intervention Group
Participants will be enrolled for a period of 4 weeks.
At baseline, we will collect demographic information on participants.
During the study, participants will be asked to fill out daily and weekly surveys using the e-PRO app.
Additionally, participants will be asked to fill out one survey once a week during the study period.
A subgroup of these participants will be asked to complete an additional interview to collect more information on their experiences using the mobile app.
|
The e-PRO app is designed to further facilitate the delivery of PRO instruments in a convenient manner to participants.
Through its computing capability, and user-friendly interface, the e-PRO app can collect data and implement complex scoring requirements, thus supporting the delivery of self-administered survey questionnaires.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Usability of e-PRO vs. emailed link: survey
大体时间:At close-out
|
A survey will be administered to compare groups on their experiences with the survey-method administration (Investigator developed survey).
The following components will be taken into account: acceptability-- participant satisfaction with various aspects of the solution (e.g.
content, complexity, comfort, delivery, and credibility).
Adoption-- participants' intention to try; perceived barriers and facilitators for uptake.
Appropriateness-- participant's perceived relevance to need; suitability to daily patient workflow.
Feasibility-- suitability for using daily, weekly etc.
This survey is not a scored survey.
|
At close-out
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Survey response rate e-PRO vs emailed link
大体时间:At close-out
|
Response rate will be tracked on a weekly basis from the e-PRO system and the REDCap embedded email link to compare response rate between the control and intervention group.
The AAOPR (2006) recommendation for RR formula will be used to calculate the RR.
This is the number of completed surveys (completed and partially completed) divided by the number of completed surveys (completed and partially completed) plus the number of all non-completed surveys (sent to a potential participant but not completed because of incorrect e-mail address, incorrect mailing address, or other reasons).
|
At close-out
|
合作者和调查者
合作者
调查人员
- 首席研究员:Ramya S Palacholla, MD, MPH、Partners HealthCare
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 2019P002811
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.